APIGENIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

The global apigenin market is estimated to be valued at USD 4.32 Mn in 2025 and is expected to reach USD 7.85 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. The global apigenin market represents a rapidly expanding segment within the nutraceuticals and pharmaceuticals industry, driven by increasing consumer awareness of natural bioactive compounds and their therapeutic benefits. Apigenin, a naturally occurring flavonoid primarily found in parsley, celery, chamomile, and various fruits and vegetables, has garnered significant attention from researchers and manufacturers due to its potent antioxidant, anti-inflammatory, and anticancer properties.

Market Dynamics

The global apigenin market is propelled by several dynamic factors that collectively shape its growth trajectory and competitive landscape. Key market drivers include the escalating demand for natural and organic ingredients across pharmaceutical, nutraceutical, and cosmetic industries, as consumers increasingly prioritize health-conscious choices and seek alternatives to synthetic compounds. The growing body of scientific evidence supporting apigenin's therapeutic properties, particularly its anti-cancer, anti-inflammatory, and anxiolytic effects, has significantly boosted market confidence and adoption rates among manufacturers and end-users.

Key Features of the Study

• This report provides in-depth analysis of the global apigenin market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global apigenin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sigma-Aldrich (Merck KGaA), Indofine Chemical Company Inc., Cayman Chemical Company, TCI Chemicals, ChemFaces, Extrasynthese., BioBioPha Co., Ltd., and Ark Pharm, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global apigenin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apigenin market

Market Segmentation

• Purity Level Insights (Revenue, USD Mn, 2020 - 2032)
  • 95-98%
  • 98-99%
  • Below 95%
• Source Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Natural Apigenin
  • Synthetic Apigenin
  • Semi-synthetic Apigenin
• Form Insights (Revenue, USD Mn, 2020 - 2032)
  • Powder
  • Liquid
  • Capsules
  • Others
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Dietary Supplements
  • Pharmaceuticals
  • Cosmetics
  • Food & Beverages
  • Others
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Sigma-Aldrich (Merck KGaA)
  • Indofine Chemical Company Inc.
  • Cayman Chemical Company
  • TCI Chemicals
  • ChemFaces
  • Extrasynthese.
  • BioBioPha Co., Ltd.
  • Ark Pharm, Inc.